NICE rejects Orchard’s gene therapy for rare childhood disease MLDOrchard Therapeutics’ gene therapy for rare childhood disease metachromatic leukodystrophy (MLD) Libmeldy has been rejected for NHS use Share XNICE rejects Orchard’s gene therapy for rare childhood disease MLDhttps://pharmaphorum.com/news/nice-rejects-orchards-gene-therapy-for-rare-childhood-disease-mld/
